CD44 and cancer: Intracellular uptake efficiency was evaluated by Cy5.5–labelled HA‐CE–based nanoparticles in the three cell lines including U87MG (low CD44 expression), MCF‐7 (high CD44 expression) and MCF‐7/ADR (high CD44 expression and showing MDR to anti‐cancer agents).